Access cutting-edge multiple myeloma treatment through this clinical trial at a research site in Stony Brook. Study-provided care at no cost to qualified participants.
Access multiple myeloma specialists in Stony Brook at no cost
This study follows strict safety protocols and ethical guidelines
All study-related multiple myeloma treatment provided free
This study is researching an experimental drug called linvoseltamab, also called REGN5458. Linvoseltamab has previously been studied by itself (without other cancer drugs) in participants who had advanced multiple myeloma that returned and needed to be treated again after many other therapies had failed. These participants were no longer benefiting from standard medications and had no good treatment options. In that study, some participants who were treated with linvoseltamab had improvement of
Sponsor: Regeneron Pharmaceuticals
Check if you qualify for this multiple myeloma clinical trial in Stony Brook, NY
If you're searching for multiple myeloma treatment options in Stony Brook, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stony Brook research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple myeloma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.